Summary.Results of 33 simultaneous pancreas and kidney transplantations performed at the San Raffaele Hospital, Milan , Italy are presented. In 26 cases segmental neoprene duct-injected grafts were transplanted and in seven cases, duodenopancreatic bladder-drained grafts. Five-year patient, kidney and pancreas survival were respectively, 89%,72% and 58%. Five-year survival in patients with technically successful pancreas transplants was 73%. Thrombosis occured in 20% of cases. Mortality was 6% and overall morbidity 76%. Surgical complications were present in 51% of cases.
Introduction
Over the past few years there have been at least two major factors which have improved the technical results of pancreas Iransplantation. First of all the ability to harvest simultaneously liver and whole pancreas with a common in situ perfusion with University of Wisconsin solution according to Starzl's procedure (Starzl 1987) . Second, the reduction of technical failures and the ability to monitor rejection with the duodenopancreatic bladder drainage technique which has been popularized by Madison's group (Sollinger 1988) .
In the light of these latest improvements we reviewed the pancreas and kidney transplantation programme at San Raffaele Hospital-Milan by considering the results in terms of survival and post-operative complications.
Subjects and Methods
At the University of Milan, San Raffaele Hospital, from July 1985 to January 1990, 33 simultaneous pancreas and kidney transplants were performed in 32 patients with Type 1 (insulin-dependent) diabetes mellitus and ureamia (one patient was pancreas and kidney retransplantexl). Three dissynehronous transplants at the very beginning of the transplantation programme were not considered in the present analysis. In 26 cases a segmental neoprene duct-injected transplantations was performed. From October 1989, seven duodenopancreatic transplantation with bladder drainage were performed. Mean age of the parents was 38.7+1.3 years, the mean duration of Type 1 diabetes 24.6+_1.1 years and the mean duration of dialysis 17.4+_2.1 months. All patients had peripheral vaseulopathy, autonomic and peripheral neuropathy and retinopathy (one patient was blind). Access was through a median laparotomy in the first 18 eases and through a bilateral pararnedian J incision in the latest cases. The segmental pancreas was duct injected with neoprene (2.5-6 ml) according to Du Bernard's technique (1978) and crafted to the iliac vessels (in 11 cases to the internal iliac artery, in 11 to the external, in three to the common and in one case to the inferior mesentetic artery). Duodenopancreatie transplants (SoUinger 1988) were grafted in all cases to the external iliae artery. In six cases an extended iliac artery graft was used and in one case an aortic patch was available. The mean warm isehaemia time was 42.4+_13 min and the mean cold ischaemia time 5 hours+ 82 min. Table 1 . Antieoagulafive protocol Induction Maintenance
July 85-March 88
Heparin Aeenoconmarole (PTr ratio>2.0) (PT ratio >1.3 <1.5)
Avri188-Sere 89 (randomized study)
Dextran Dipiridamole (75 mg rid*) (250ml/day) ASA (250 mg uidt)
V8
Antithrombin HI Acenoeournarole (100 UI/h) (fir ratio >1.3 <1.5) followed by Calcium Heparin (0.2 ml tid*)
from October ~9 Calcium Heparin Dipiridamole (75 mg rid*) (0.2 ml rid*) ASA (100 mg uldt) *rid = three times daily tuid = once daffy $12
To prevent graft thrombosis padents underwent an anticoagulafive protocol which changed with time (Table 1) The immunosuppressive proto9ol included azathioprine (2.5 mg.kg-l.day -1, maintenance 1 mg.kg-l.day "1) Prednisone (10 mg.kg'l.day "1, progressiv?l~ red.~d to 10rag.day), Antilymphoeyte globulins (ALG) (8 mg.kg" .day-for 10 days). ALG was then withdrawn and 6-8 mg.kg-1 .day-1 of cyclosporin was administered. Acute rejection episodes were treated by methylprednisolone flushes (500 nag). From October 1989 the immunosuppressive protocol was modified in the following way: Prednisone (1 mg.kg-l.day "], maintenance 10 rag.day). Unresponsive acute rejection episodes were treated with OKT3 monocolonal antibodies. All patients underwent peTi-operative antibiotic prophylaxis with a 3 rd generation cephalosporin and long-term prophylaxis with cotfimoxazole. Antifungal and antiviral prophylaxis were performed with ketoconazole and acyelovir.
Results
Patient, kidney and pancreas actuarial survival are shown in Figure 1 . Patient 1-year and 2-year survival were respectively, 93 and 89 %, which remained unchanged for 5 years.
Kidney 1-year survival was still 93% while 5-year was 72% mainly due to chronic rejections.
Pancreas 1-year survival was 68%, the 5-year rate was 58%. Most of the failures were observed during the first 3 month period. Late failures were caused by chronic rejection. One-year and 5-year pancreas graft survival in technical successful cases were 88% and 73%.
The overall mortality was 6% : one patient died of myocardial infarction with both organs functioning and one patient died of septic bleeding after the removal of both the organs. A quarter of the transplantations had an uneventful postoperative course (24.4%). Surgical complications were present in 51% of patients while 71% of patientsshowed rejection or complications related to immunosuppressive therapy and 43% of the cases had nonsurgical infections.
Causes of graft failure ~ are reported in Table 2 . Twenty pancreas grafts have been functioning from 5 to 66 months and in 26 cases the grafted kidney is still functioning after the same follow-up period. Pancreas function failure was due to thrombosis in seven cases (20%) and rejection in four cases (12%). Kidney failure was mainly secondary to chronic rejection (after a mean of 30 months). In only one case a surgical complication was the reason for loss of kidney graft function due to pancreas graft abscess. Acute kidney rejection was observed in 19 cases and in four cases a chronic rejection ensued ( after a mean of 30 months) which led to the loss of function. Severe acute pancreas rejection was observed in two cases. In one of them pancreas function recovered completely after treatment Fourteen patients had one or more non-surgical infection (13 cytomegalovims, 8 herpes simplex virus , 2 herpes zoster virus infections). In one case a Staphilococcus Aureus Endocarditis and in another a Guillain-Barre Syndrome was observed. Seventeen patients (51%) had a post-operative surgical complication. In nine cases (27%) the surgical complication led to graft failure, in one case (3.6%) to death and in seven cases a relapamtomy was needed (21%). Arterial or venous thrombosis were the most common complications (21%) Pancreas [n = 13 cases (39%)] *thrombosis 7(20%) *rejection 4(12%) *primary non-function 1 (3%) *death with functioning graft 1 (3%) Kidney [n = 6 cases (18%)] *rejection 4 (12%) *thrombosis 1 (3%) *death with functioning graft 1 (3%) In five patients (15%) a pancreatic fistula developed. In all cases the fistula healed in less than 2 weeks and in only one case was complicated by an infection which required a relaparotomy for peritonitis. The heavy anticoagulative protocol during the early experience lead to haemoperitoneum in two cases for which one required relaparotomy.
Two patients developed a septic haemorrhagic complication which required relapamtomy.The first patient had a thrombosed pancreas, and a vasculitis of the anastomosis secondary to peripancreatic abscess which caused a septic bleeding. The pancreas graft was removed and the patient died on the 6th day after the relaparotomy. The second patient had a localized stump pancreatitis, complicated with infection which caused a septic bleeding.
Discussion
Pancreas transplantation together with kidney transplantation as treatment of end-stage renal failure in diabetic patients remains somewhat controversial despite reports showing an improved success rate for both organs. Overall results of pancreas graft survival are still hindered by technical failures. In North American centres technical failures were recently reduced to 5-10% due to the use of the whole pancreas-bladder drainage technique. Our overall results, comparing the group of neoprene ductinjection and bladder drainage technique showed a 20% failure rate due to technical causes which requires further improvements. Pancreas graft rejections were observed in five cases (in two cases early and three delayed). In only one case of the latest bladder drainage series, an early acute rejection could be clearly documented, healed and treated. The bladder drainage technique allowed monitoring of amylasuria and the performance of diagnostic fine needle aspiration biopsy. Such diagnostic techniques were essential in treating and reversing rejection. The overall morbidity rate could be considered acceptable (51%) but the quality of major complications which required relaparotomy is still a heavy burden for patients who are already at high risk for surgical procedures. The mortality rate is comparable to that observed in major elective surgical procedures. In our study post-operative deaths were accounted for by the critical cardiac conditions, which pointed out the need of a more severe cardiologic work-up for selection, and by surgical complications such as septic bleeding which was potentially lethal in these patients. Thus, a more aggressive post-operative surveillance and treatment for surgical complications is warranted.
